Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Riyuechang Technology is a Chinese biotechnology company specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) products. Founded in 2013 and headquartered in Shenzhen, the company focuses on point-of-care testing (POCT) solutions, particularly through its fluorescence immunoassay and colloidal gold platforms. Their product portfolio includes automated quantitative analyzers and a wide range of test kits for cardiovascular markers, inflammatory indicators, diabetes management, and infectious diseases. Riyuechang's systems are designed for use in clinical laboratories, emergency departments, and primary care settings to provide rapid and reliable diagnostic results. The company maintains international quality standards, including ISO 13485 certification, and distributes its products to both domestic and global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Riyuechang Technology.